TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
GNLX

Genelux Corporation

Healthcare · Biotechnology

2.60$ +1.6% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow GNLX
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +37.9% +36.0% +8.2% +5.2% -11.3% -73.0%
– – -19.8% -43.5% +115.5% +16.6% -3.3%
– +38.4% -13.3% -54.5% – – –
– +353.6% +971.7% -141.4% – – -239.3%
– -98.9% +145.0% +0.0% +1,991.8% -62.8% +188.2%
– -98.9% +145.0% +0.0% +29,949.0% -44.8% –
– +508.7% -106.1% – -77.8% -100.0% –
– +130.1% -101.5% +77.0% – -35.2% -65.3%
– – -162.7% – – -109.5% –
– – – – – – –

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?